The University of South Florida (USF) has opened the Center for Memory C.A.R.E. (Clinical Assessment, Research and Education), on the second floor of the six-story USF Health Byrd Alzheimer’s Institute, to support patients and their caregivers.

The University of California (UC), San Diego Health Sciences has joined other U.S. life science research institutions as part of Pfizer's Centers for Therapeutic Innovation.

The Alzheimer's Drug Discovery Foundation, based in New York City, will provide Melbourne, Australia-based Prana Biotechnology an investment of $700,000 over two years to conduct a clinical trial investigating the potential of PBT2 to reduce the accumulation of beta-amyloid in the brain of people with Alzheimer's disease. PET amyloid neuroimaging and other biomarkers will be used as the primary outcome measures.